| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |